Page last updated: 2024-10-26

dipyridamole and Acute Lymphoid Leukemia

dipyridamole has been researched along with Acute Lymphoid Leukemia in 3 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Motoyama, O1
Kojima, Y1
Ohara, A1
Tsukimoto, I1
Ishikawa, Y1
Iitaka, K1
Sotomatsu, M1
Yugami, S1
Shitara, T1
Kuroume, T1
Takimoto, T1
Kitoh, T1
Tanizawa, A1
Akiyama, Y1
Kiriyama, Y1
Kubota, M1
Mikawa, H1

Other Studies

3 other studies available for dipyridamole and Acute Lymphoid Leukemia

ArticleYear
IgA nephropathy associated with leukemia and lymphoma: report of two cases.
    Clinical and experimental nephrology, 2008, Volume: 12, Issue:2

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Di

2008
Dipyridamole enhancement of drug sensitivity in acute lymphoblastic leukemia cells.
    American journal of hematology, 1993, Volume: 43, Issue:4

    Topics: Administration, Oral; Antineoplastic Agents; Bone Marrow; Child; Dipyridamole; Dose-Response Relatio

1993
Characterization of nucleoside transport during leukemic cell differentiation.
    Advances in experimental medicine and biology, 1989, Volume: 253B

    Topics: Biological Transport; Cell Differentiation; Cytarabine; Deoxycytidine Kinase; Dipyridamole; Humans;

1989